🔎 Trials Near Me

Akèy › Twoub depresif majè › Ohio › Cincinnati

Etid klinik pou Twoub depresif majè nan Cincinnati, OH

11 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Cincinnati (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Patient Priority Clinical Sites LLC, Cincinnati
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Ap rekriteFaz 3
  • Patient Priority Clinical Sites LLC, Cincinnati
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT06559306

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Ap rekriteFaz 3
  • University of Cincinnati Medical Center, Cincinnati
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT05850689

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 3
  • University of Cincinnati, Cincinnati
Laj 12 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT07227454

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Ap rekriteFaz 3
  • Vanda Investigational Site, Cincinnati
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT06830044

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Mason · 19 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06911112

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains

Ap rekriteFaz 1/2
  • Lindner Center of Hope, Mason · 19 mi lwen
Laj 18 a 60 · Tout sèks · Mizajou Aug 3, 2026 · NCT06795451

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Ap rekriteFaz 3
  • Clinical Research Site, Cincinnati
  • Clinical Research Site, Cincinnati
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT07484217

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

Ap rekrite
  • Cincinnati Childrens Hospital Medical Center, Cincinnati
Laj 14 a 18 · Tout sèks · Mizajou Feb 11, 2026 · NCT07217444

Study of ALTO-300 in MDD

Ap rekriteFaz 2
  • Site 202, Cincinnati
Laj 18 a 70 · Tout sèks · Mizajou Jul 24, 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Ap rekriteFaz 4
  • Clinical Research Site, Cincinnati
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Cincinnati

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.